On day 8 after DSS administration, control Kng1+/+ mice developed severe colitis, with symptoms including body weight loss, loose stool consistency, and gross bleeding, as demonstrated by the DAI compared to that of DW-treated mice (Figures 1C,D). Here, KNG1 is linked to colitis.